Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.
about
Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancerRegulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer.The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer.ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function.
P2860
Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Estrogen receptor beta as a pr ...... atic review and meta-analysis.
@en
type
label
Estrogen receptor beta as a pr ...... atic review and meta-analysis.
@en
prefLabel
Estrogen receptor beta as a pr ...... atic review and meta-analysis.
@en
P2093
P2860
P31
P921
P356
P1433
P1476
Estrogen receptor beta as a pr ...... atic review and meta-analysis.
@en
P2093
P2860
P304
10373-10385
P356
10.18632/ONCOTARGET.7219
P407
P5008
P577
2016-02-06T00:00:00Z
2016-03-01T00:00:00Z